Related Experiment Video
Updated: Dec 12, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy
Christoph Schukro1, David Santer2, Günther Prenner3
1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Abstract:
Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Cardiac Catheterization IV: Nursing Management
Heart Failure VI: Adjunct Therapies
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy II: Dilated Cardiomyopathy

